Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Zhenglong Jin"'
Autor:
Jian Miao, Hongfei Sang, Fengli Li, Jeffrey L. Saver, Bo Lei, Jinglun Li, Raul Gomes Nogueira, Bo Song, Shudong Liu, Thanh N. Nguyen, Zhenglong Jin, Hongliang Zeng, Changming Wen, Guangxiong Yuan, Weilin Kong, Weidong Luo, Shuai Liu, Dongjing Xie, Jiacheng Huang, Chang Liu, Jie Yang, Jinrong Hu, Jiaxing Song, Chengsong Yue, Linyu Li, Yan Tian, Xiao Zhang, Dan Feng, Yani Gao, Huiying Fu, Wenjie Zi, Qingwu Yang, Zhongming Qiu, Shaojun Wang
Publikováno v:
Stroke. 54:1569-1577
Background: The effect of imaging selection paradigms on endovascular thrombectomy outcomes in patients with acute ischemic stroke with large vessel occlusion remains uncertain. The study aimed to assess the effect of basic imaging (noncontrast compu
Autor:
Jie Yang, Zhenglong Jin, Jiaxing Song, Changwei Guo, Dongjing Xie, Chengsong Yue, Weilin Kong, Jinrong Hu, Weidong Luo, Shuai Liu, Jiacheng Huang, Guoyong Zeng
Publikováno v:
Neurosurgery. 92:1006-1012
Autor:
Zhongming Qiu, Junjie Yuan, Dongjing Xie, Deping Wu, Weidong Luo, Tao Zhaojun, Shuai Liu, Qin Han, Dong Sun, Bo Lei, Jinglun Li, Jian Miao, Shudong Liu, Zhenglong Jin, Guoyong Zeng, Changming Wen, Guangxiong Yuan, Qingwu Yang, Thanh Nguyen, Jeffrey L Saver, Raul G Nogueira, Fengli Li, Hongfei Sang, Wenjie Zi
Publikováno v:
Stroke. 54
Background: In acute ischemic stroke patients with large vessel occlusion, the role of intravenous tirofiban or alteplase as an adjunct to endovascular treatment (EVT) is still uncertain. Methods: This post hoc analysis used data from 467 patients in
Astragaloside IV alleviates neuronal ferroptosis in ischemic stroke by regulating FTO-m6A-ACSL4 axis
Background Ischemic stroke (IS) is a detrimental neurological disease with limited treatments options. Astragaloside IV (As-IV) was a promising bioactive constituent in the treatment of IS. However, the functional mechanism remains unclear. Methods I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ff07f9d52ac0d52f5d6e44fd617a5bd
https://doi.org/10.21203/rs.3.rs-2047265/v1
https://doi.org/10.21203/rs.3.rs-2047265/v1
Publikováno v:
World neurosurgery. 168
To develop and validate a model for predicting the risk of recurrent stroke among middle-aged and elderly stroke patients.A total of 1,327 stroke patients from the China Health and Retirement Longitudinal Study (CHARLS) were included in the retrospec
Autor:
Zhongming Qiu, Fengli Li, Hongfei Sang, Weidong Luo, Shuai Liu, Wenhua Liu, Zhangbao Guo, Huagang Li, Dong Sun, Wenguo Huang, Min Zhang, Weipeng Dai, Peiyang Zhou, Wei Deng, Zhiming Zhou, Xianjun Huang, Bo Lei, Jinglun Li, Zhengzhou Yuan, Bo Song, Jian Miao, Shudong Liu, Zhenglong Jin, Guoyong Zeng, Hongliang Zeng, Junjie Yuan, Changming Wen, Yang Yu, Guangxiong Yuan, Junxiong Wu, Chen Long, Jun Luo, Zhenxuan Tian, Chong Zheng, Zhizhou Hu, Shouchun Wang, Tao Wang, Li Qi, Rongzong Li, Yue Wan, Yingbing Ke, Youlin Wu, Xiurong Zhu, Weilin Kong, Jiacheng Huang, Daizhou Peng, Mingze Chang, Hanming Ge, Zhonghua Shi, Zhizhong Yan, Jie Du, Ying Jin, Dongsheng Ju, Chuming Huang, Yifan Hong, Tianzhu Liu, Wenlong Zhao, Jian Wang, Bo Zheng, Li Wang, Shugai Liu, Xiaojun Luo, Shiwei Luo, Xinwei Xu, Jinrong Hu, Jie Pu, Shengli Chen, Yaxuan Sun, Shunfu Jiang, Liping Wei, Xinmin Fu, Yongjie Bai, Shunyu Yang, Wei Hu, Guling Zhang, Chengde Pan, Shuai Zhang, Yan Wang, Wenfeng Cao, Shiquan Yang, Jun Zhang, Fuqiang Guo, Hongbin Wen, Jinghua Zhang, Jiaxing Song, Chengsong Yue, Linyu Li, Deping Wu, Yan Tian, Jie Yang, Mengjie Lu, Jeffrey Saver, Raul Gomes Nogueira, Wenjie Zi, QingWu Yang
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Molecular Medicine Reports
Psoralen (PSO) exerts anti-inflammatory pharmacological effects and plays an important role in a variety of inflammatory diseases. However, the effects of PSO with allergic rhinitis (AR) are yet to be reported. In the present study, an in vitro AR mo
Autor:
Zhongming, Qiu, Fengli, Li, Hongfei, Sang, Weidong, Luo, Shuai, Liu, Wenhua, Liu, Zhangbao, Guo, Huagang, Li, Dong, Sun, Wenguo, Huang, Min, Zhang, Weipeng, Dai, Peiyang, Zhou, Wei, Deng, Zhiming, Zhou, Xianjun, Huang, Bo, Lei, Jinglun, Li, Zhengzhou, Yuan, Bo, Song, Jian, Miao, Shudong, Liu, Zhenglong, Jin, Guoyong, Zeng, Hongliang, Zeng, Junjie, Yuan, Changming, Wen, Yang, Yu, Guangxiong, Yuan, Junxiong, Wu, Chen, Long, Jun, Luo, Zhenxuan, Tian, Chong, Zheng, Zhizhou, Hu, Shouchun, Wang, Tao, Wang, Li, Qi, Rongzong, Li, Yue, Wan, Yingbing, Ke, Youlin, Wu, Xiurong, Zhu, Weilin, Kong, Jiacheng, Huang, Daizhou, Peng, Mingze, Chang, Hanming, Ge, Zhonghua, Shi, Zhizhong, Yan, Jie, Du, Ying, Jin, Dongsheng, Ju, Chuming, Huang, Yifan, Hong, Tianzhu, Liu, Wenlong, Zhao, Jian, Wang, Bo, Zheng, Li, Wang, Shugai, Liu, Xiaojun, Luo, Shiwei, Luo, Xinwei, Xu, Jinrong, Hu, Jie, Pu, Shengli, Chen, Yaxuan, Sun, Shunfu, Jiang, Liping, Wei, Xinmin, Fu, Yongjie, Bai, Shunyu, Yang, Wei, Hu, Guling, Zhang, Chengde, Pan, Shuai, Zhang, Yan, Wang, Wenfeng, Cao, Shiquan, Yang, Jun, Zhang, Fuqiang, Guo, Hongbin, Wen, Jinhua, Zhang, Jiaxing, Song, Chengsong, Yue, Linyu, Li, Deping, Wu, Yan, Tian, Jie, Yang, Mengjie, Lu, Jeffrey L, Saver, Raul G, Nogueira, Wenjie, Zi, Hua, Yang
Publikováno v:
JAMA. 328:543
Tirofiban is a highly selective nonpeptide antagonist of glycoprotein IIb/IIIa receptor, which reversibly inhibits platelet aggregation. It remains uncertain whether intravenous tirofiban is effective to improve functional outcomes for patients with